| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Oct 24 | CTLT Catalent | Common Stock | Grant | Acquire A | No | No | 0 | 4,663 | 0.00 | 12,635 |
| 7 Jun 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,400 | 0.00 | 9,400 |
| 7 Jun 24 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 44.71 | 12,500 | 558.88 k | 12,500 |
| 28 Mar 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 46.38 | 17,500 | 811.65 k | 6,000 |
| 28 Mar 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 18.29 | 17,500 | 320.08 k | 23,500 |
| 28 Mar 24 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Option exercise | Acquire M | No | No | 18.29 | 17,500 | 320.08 k | 0 |
| 15 Feb 24 | PTCT PTC Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 9,867 |
| 15 Feb 24 | PTCT PTC Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.69 | 10,000 | 256.90 k | 10,000 |
| 27 Oct 23 | CTLT Catalent | Common Stock | Grant | Acquire A | No | No | 0 | 6,993 | 0.00 | 7,972 |
